Brazil
Egypt
Europe
Hong Kong
Malaysia
Mexico
Morocco
Philippines
Saudi Arabia
South Africa
Taiwan
Thailand
Tunisia
Turkey
UAE
USA
Vietnam
Canada
Global HQ
Scott Tomsky
Global Head of Regulatory Affairs
Scott Tomsky
Global Head of Regulatory Affairs
Scott Tomsky serves as the Global Head of Regulatory Affairs at Biocon Biologics, where he leads the company’s worldwide regulatory strategy and oversees all regulatory functions across markets.
Scott joined Biocon Biologics in January 2026, bringing with him more than 25 years of extensive experience in Regulatory Affairs across CMC, generics, biosimilars, and lifecycle management. Over the course of his career, he has held senior leadership roles at Organon, Teva Pharmaceuticals, Ranbaxy, and McNeil Consumer Healthcare.
Over the years, he has also led Pharmacovigilance functions, contributed to industry associations including Association for Accessible Medicines (AAM) and Canadian Generic Pharmaceutical Association (CGPA) advisory boards, and supported U.S. Food and Drug Administration’s Generic Drug User Fee Amendments (GDUFA) negotiations.
Known for building high‑performance teams and driving execution excellence, he is widely recognized for fostering strong cross‑functional collaboration while upholding the highest standards of quality and compliance.
Scott holds a Master of Science degree in Quality Assurance/Regulatory Affairs from the Temple University School of Pharmacy, and a Bachelor of Science in Biology and Chemistry from The College of New Jersey.
Scott is on the Executive Leadership Team of Biocon Biologics.
